Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADAM22 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | SNAP25 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | KMT5C | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | BCL2 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | ZNF766 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | DCHS1 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-09 |
mRNA | PIAS2 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | CEP68 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
mRNA | GATS | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | MAST1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |